Sift Biosciences is developing a peptide-based immunotherapy platform designed to harness pre-existing immune memory.
The company aims to activate memory T cells to generate more consistent immune engagement, with applications across oncology and autoimmune diseases and an initial focus on immunologically cold solid tumors such as microsatellite-stable colorectal and ovarian cancers.
Leadership & Board
Current Number of Employees9
Current LinkedIn Followers1,243
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$4M
Total Amount Raised$4M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$4M
Latest Funding Amount$4M
Latest Funding RoundPre-Seed
Latest Funding RoundPre-Seed
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Sift Biosciences had 9 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
9Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Sift Biosciences had 1,243 followers as of September 14, 2026. The number of followers increased by 21 (1.72%) week-over-week.
1,243Latest Followers Count
21(1.72%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.